Place in therapy of key treatments for platinum-sensitive, relapsed, extensive-stage small cell lung cancer with a focus on lurbinectedin: a narrative review with case studies
Background: Virtually all patients with extensive-stage small cell lung cancer (SCLC) develop resistance to firstline platinum-based chemoimmunotherapy and experience relapse. Second-line therapy is therefore an integral part of the treatment paradigm. Methods: Evidence was reviewed for key sec...
Gardado en:
| Principais autores: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioExcel Publishing Ltd
2025-10-01
|
| Series: | Drugs in Context |
| Assuntos: | |
| Acceso en liña: | https://www.drugsincontext.com/place-in-therapy-of-key-treatments-for-platinum-sensitive-relapsed-extensive-stage-small-cell-lung-cancer-with-a-focus-on-lurbinectedin-a-narrative-review-with-case-studies/ |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|